risankizumab
UkraineMedications containing this active substance
-
Skyrizi
Form: solution for injection
Active substance Dosage risankizumab 150 mg/ml ATC: L04AC18
Manufacturer: AbbVie Biotechnology Ltd (manufacturing of medicinal product, testing, primary packaging)